VIVEbiotech is a GMP CDMO specializing in lentiviral vectors. Based in Donostia–San Sebastián, Spain, the company focuses exclusively on the manufacture of research-grade, preclinical-grade, and cGMP-grade lentiviral vectors, for both ex vivo and in vivo administration development. Founded in 2015, VIVEbiotech is a European lentiviral CDMO leader, having fulfilled contracts with over 50 companies under both EMA and FDA standards.